Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is TERIFLUNOMIDE, with a corresponding US DMF Number 29851.
Remarkably, this DMF maintains an Active status since its submission on October 21, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 16, 2015, and payment made on October 16, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II